Lenti-luciferase-P2A-Neo Citations (16)

Originally described in: A TFIID-SAGA Perturbation that Targets MYB and Suppresses Acute Myeloid Leukemia.
Xu Y, Milazzo JP, Somerville TDD, Tarumoto Y, Huang YH, Ostrander EL, Wilkinson JE, Challen GA, Vakoc CR Cancer Cell. 2018 Jan 8;33(1):13-28.e8. doi: 10.1016/j.ccell.2017.12.002. PubMed Journal

---

Articles Citing Lenti-luciferase-P2A-Neo

Articles
TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma. Somerville TDD, Xu Y, Miyabayashi K, Tiriac H, Cleary CR, Maia-Silva D, Milazzo JP, Tuveson DA, Vakoc CR. Cell Rep. 2018 Nov 13;25(7):1741-1755.e7. doi: 10.1016/j.celrep.2018.10.051. PubMed
Zikavirus prME Envelope Pseudotyped Human Immunodeficiency Virus Type-1 as a Novel Tool for Glioblastoma-Directed Virotherapy. Kretschmer M, Kadlubowska P, Hoffmann D, Schwalbe B, Auerswald H, Schreiber M. Cancers (Basel). 2020 Apr 18;12(4). pii: cancers12041000. doi: 10.3390/cancers12041000. PubMed
Transcriptional Silencing of ALDH2 Confers a Dependency on Fanconi Anemia Proteins in Acute Myeloid Leukemia. Yang Z, Wu XS, Wei Y, Polyanskaya SA, Iyer SV, Jung M, Lach FP, Adelman ER, Klingbeil O, Milazzo JP, Kramer M, Demerdash OE, Chang K, Goodwin S, Hodges E, McCombie WR, Figueroa ME, Smogorzewska A, Vakoc CR. Cancer Discov. 2021 Sep;11(9):2300-2315. doi: 10.1158/2159-8290.CD-20-1542. Epub 2021 Apr 23. PubMed
Rapid interrogation of cancer cell of origin through CRISPR editing. Feng W, Cao Z, Lim PX, Zhao H, Luo H, Mao N, Lee YS, Rivera AA, Choi D, Wu C, Han T, Romero R, de Stanchina E, Carver BS, Wang Q, Jasin M, Sawyers CL. Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). pii: 2110344118. doi: 10.1073/pnas.2110344118. PubMed
SLC5A3-Dependent Myo-inositol Auxotrophy in Acute Myeloid Leukemia. Wei Y, Huang YH, Skopelitis DS, Iyer SV, Costa ASH, Yang Z, Kramer M, Adelman ER, Klingbeil O, Demerdash OE, Polyanskaya SA, Chang K, Goodwin S, Hodges E, McCombie WR, Figueroa ME, Vakoc CR. Cancer Discov. 2022 Feb;12(2):450-467. doi: 10.1158/2159-8290.CD-20-1849. Epub 2021 Sep 16. PubMed
SCP4-STK35/PDIK1L complex is a dual phospho-catalytic signaling dependency in acute myeloid leukemia. Polyanskaya SA, Moreno RY, Lu B, Feng R, Yao Y, Irani S, Klingbeil O, Yang Z, Wei Y, Demerdash OE, Benjamin LA, Weiss MJ, Zhang YJ, Vakoc CR. Cell Rep. 2022 Jan 11;38(2):110233. doi: 10.1016/j.celrep.2021.110233. PubMed
Gene expression predicts dormant metastatic breast cancer cell phenotype. Ren Q, Khoo WH, Corr AP, Phan TG, Croucher PI, Stewart SA. Breast Cancer Res. 2022 Jan 29;24(1):10. doi: 10.1186/s13058-022-01503-5. PubMed
Sequence-specific capture and concentration of viral RNA by type III CRISPR system enhances diagnostic. Nemudraia A, Nemudryi A, Buyukyoruk M, Scherffius A, Zahl T, Wiegand T, Pandey S, Nichols J, Hall L, McVey A, Lee H, Wilkinson R, Snyder L, Jones J, Koutmou K, Santiago-Frangos A, Wiedenheft B. Res Sq. 2022 Apr 19. doi: 10.21203/rs.3.rs-1466718/v1. PubMed
Development and Characterization of a Luciferase Labeled, Syngeneic Murine Model of Ovarian Cancer. Russell S, Lim F, Peters PN, Wardell SE, Whitaker R, Chang CY, Previs RA, McDonnell DP. Cancers (Basel). 2022 Aug 30;14(17):4219. doi: 10.3390/cancers14174219. PubMed
Increased CaMKK2 Expression Is an Adaptive Response That Maintains the Fitness of Tumor-Infiltrating Natural Killer Cells. Juras PK, Racioppi L, Mukherjee D, Artham S, Gao X, Akullian D'Agostino L, Chang CY, McDonnell DP. Cancer Immunol Res. 2023 Jan 3;11(1):109-122. doi: 10.1158/2326-6066.CIR-22-0391. PubMed
Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Dai T, Rosario SR, Katsuta E, Sawant Dessai A, Paterson EJ, Novickis AT, Cortes Gomez E, Zhu B, Liu S, Wang H, Abrams SI, Seshadri M, Bshara W, Dasgupta S. Cell Rep. 2022 Dec 6;41(10):111756. doi: 10.1016/j.celrep.2022.111756. PubMed
P2RX7 promotes osteosarcoma progression and glucose metabolism by enhancing c-Myc stabilization. Sheng G, Gao Y, Ding Q, Zhang R, Wang T, Jing S, Zhao H, Ma T, Wu H, Yang Y. J Transl Med. 2023 Feb 20;21(1):132. doi: 10.1186/s12967-023-03985-z. PubMed
IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma. Swan SL, Mehta N, Ilich E, Shen SH, Wilkinson DS, Anderson AR, Segura T, Sanchez-Perez L, Sampson JH, Bellamkonda RV. Front Immunol. 2023 Feb 3;14:1085547. doi: 10.3389/fimmu.2023.1085547. eCollection 2023. PubMed
Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Chang Y, Jin G, Luo W, Luo Q, Jung J, Hummel SN, Torregrosa-Allen S, Elzey BD, Low PS, Lian XL, Bao X. Bioact Mater. 2023 Apr 5;27:168-180. doi: 10.1016/j.bioactmat.2023.03.018. eCollection 2023 Sep. PubMed
A role for microsomal glutathione transferase 1 in melanin biosynthesis and melanoma progression. Zhang J, Ye ZW, Brautigam L, Chakraborty P, Luo Z, Culpepper J, Aslam M, Zhang L, Johansson K, Haeggstrom JZ, Xu J, Olsson M, Townsend DM, Mehrotra S, Morgenstern R, Tew KD. J Biol Chem. 2023 Jun 14;299(8):104920. doi: 10.1016/j.jbc.2023.104920. PubMed
The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2. Chaib S, Lopez-Dominguez JA, Lalinde-Gutierrez M, Prats N, Marin I, Boix O, Garcia-Garijo A, Meyer K, Munoz MI, Aguilera M, Mateo L, Stephan-Otto Attolini C, Llanos S, Perez-Ramos S, Escorihuela M, Al-Shahrour F, Cash TP, Tchkonia T, Kirkland JL, Abad M, Gros A, Arribas J, Serrano M. Nat Cancer. 2024 Jan 24. doi: 10.1038/s43018-023-00712-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.